Long-Term Clinical Outcomes of Kidney Transplantation from Hepatitis B Surface Antigen (HBsAg)-Positive Donors to HBsAg-Negative Recipients: A Systematic Review and Meta-Analysis of Real-World Studies
Journal of Clinical Medicine · 04.08.2026 · 15 (15) · 6048
DOI: 10.3390/jcm15156048 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.08.2026. Verfasst von Chengze Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610093, China. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The use of hepatitis B surface antigen-positive (HBsAg+) kidneys may expand the donor pool for transplantation. This study evaluated the incidence, risk factors, complications, organ function, and survival outcomes of transplants from HBsAg+ donors to HBsAg− recipients.
Methods
A systematic search of five databases was conducted through 20 August 2023. Incidence was expressed with 95% confidence intervals (CIs); odds ratios (ORs) and hazard ratios (HRs) assessed risk factors and survival.
Results
Sixteen studies were included. Donor-derived HBV infection occurred in 3.60% (21/583). Risk was higher in HBsAb-negative (OR: 6.67, 95% CI: 1.08–41.10) and HBcAb-negative recipients (OR: 12.96, 95% CI: 2.06–81.69). Abnormal liver function occurred in 35.18%, hepatitis in 3.07%, and hepatic failure in 0.84%. Liver and kidney function at 1–3 years were comparable between HBsAg+ and HBsAg− kidney recipients. Five- and ten-year graft survival (85.2%, 82.7%) and patient survival (93.0%, 91.4%) were similar to controls (p > 0.05).
Conclusions
HBsAg+ kidneys can achieve acceptable long-term outcomes with appropriate antiviral prophylaxis and cautious recipient selection, though infection risk requires careful assessment. These findings supports the cautious and selective use of HBsAg-positive kidneys in appropriately selected recipients use and standardized HBV prophylaxis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Institute of Urology, West China Hospital, Sichuan University, Chengdu 610093, China.
- West China Medical School of Sichuan University, Chengdu 610093, China.
- Kidney Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China.
- Organ Transplantation Center, West China Hospital, Sichuan University, Chengdu 610093, China.
ORCID-Profile: Chengze Liang
Zitieren
APA
Liang, C., Luo, Y., Yin, S., Song, T., & Lin, T. (2026). Long-Term Clinical Outcomes of Kidney Transplantation from Hepatitis B Surface Antigen (HBsAg)-Positive Donors to HBsAg-Negative Recipients: A Systematic Review and Meta-Analysis of Real-World Studies. Journal of Clinical Medicine, 15(15), 6048. https://doi.org/10.3390/jcm15156048
Vancouver
Liang C, Luo Y, Yin S, Song T, Lin T. Long-Term Clinical Outcomes of Kidney Transplantation from Hepatitis B Surface Antigen (HBsAg)-Positive Donors to HBsAg-Negative Recipients: A Systematic Review and Meta-Analysis of Real-World Studies. Journal of Clinical Medicine. 2026;15(15):6048. doi:10.3390/jcm15156048
BibTeX
@article{Liang2026,
author = {Liang, Chengze and Luo, Yun and Yin, Saifu and Song, Turun and Lin, Tao},
title = {Long-Term Clinical Outcomes of Kidney Transplantation from Hepatitis B Surface Antigen (HBsAg)-Positive Donors to HBsAg-Negative Recipients: A Systematic Review and Meta-Analysis of Real-World Studies},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {15},
pages = {6048},
doi = {10.3390/jcm15156048}
}
EUVIMED